Kezar Life Sciences Inc (KZR) — Financial Flexibility Index
Kezar Life Sciences Inc (KZR) has a Financial Flexibility Index of -2.70x as of March 2026. Free cash flow of $-7.45 Million (operating CF $-7.45 Million minus capex $0.00) represents -3% of total liabilities ($2.76 Million). Check KZR goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kezar Life Sciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Kezar Life Sciences Inc across 10 annual periods. For the full cash flow conversion analysis, see Kezar Life Sciences Inc (KZR) cash flow conversion.
Annual Financial Flexibility Index for Kezar Life Sciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Kezar Life Sciences Inc. Explore Kezar Life Sciences Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -7.87x | $-51.77 Million | $-51.78 Million | $6.57 Million | ▼ -194.7% |
| 2024 | -2.67x | $-74.18 Million | $-74.21 Million | $27.77 Million | ▼ -12.7% |
| 2023 | -2.37x | $-79.83 Million | $-81.64 Million | $33.66 Million | ▼ -23.0% |
| 2022 | -1.93x | $-57.27 Million | $-58.85 Million | $29.70 Million | ▲ +3.6% |
| 2021 | -2.00x | $-42.12 Million | $-42.44 Million | $21.06 Million | ▲ +40.9% |
| 2020 | -3.38x | $-36.76 Million | $-36.95 Million | $10.86 Million | ▼ -32.5% |
| 2019 | -2.55x | $-29.27 Million | $-29.88 Million | $11.47 Million | ▲ +23.6% |
| 2018 | -3.34x | $-19.67 Million | $-20.79 Million | $5.88 Million | ▼ -3360.0% |
| 2017 | -0.10x | $-7.72 Million | $-8.11 Million | $79.91 Million | ▲ +71.0% |
| 2016 | -0.33x | $-9.63 Million | $-9.76 Million | $28.85 Million | — |